Francesca Schieppati

618 total citations
30 papers, 301 citations indexed

About

Francesca Schieppati is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Francesca Schieppati has authored 30 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 13 papers in Genetics and 9 papers in Oncology. Recurrent topics in Francesca Schieppati's work include Acute Myeloid Leukemia Research (7 papers), COVID-19 Clinical Research Studies (6 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Francesca Schieppati is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), COVID-19 Clinical Research Studies (6 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Francesca Schieppati collaborates with scholars based in Italy, United States and Mexico. Francesca Schieppati's co-authors include Anna Falanga, Domenico Russo, Laura Russo, Giuseppe Rossi, Chiara Pagani, Marina Marchetti, Elisa Cerqui, Angela Passi, Erika Borlenghi and Alessandra Tucci and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Francesca Schieppati

26 papers receiving 295 citations

Peers

Francesca Schieppati

HEMAT

GENET

ONCOL

IMMUN

Michael Jaglal United States

Shinya� Fujita Japan

Sandeep K. Rajan United States

Ilya Kirgner Israel

Guillaume Mourey France

D. Anthony Barcel United States

Kristell Desseaux France

Catherine Trichet France

M. Kerowgan Germany

Manuel Campos Portugal

Michael Jaglal United States

Francesca Schieppati

89 ×0.8

HEMAT

96 ×1.1

GENET

148 ×1.8

ONCOL

62 ×0.8

45 ×1.0

IMMUN

Citations per year, relative to Francesca Schieppati Francesca Schieppati (= 1×) peers Michael Jaglal

Countries citing papers authored by Francesca Schieppati

Since Specialization

Citations

This map shows the geographic impact of Francesca Schieppati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Schieppati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Schieppati more than expected).

Fields of papers citing papers by Francesca Schieppati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Schieppati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Schieppati. The network helps show where Francesca Schieppati may publish in the future.

Co-authorship network of co-authors of Francesca Schieppati

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Schieppati. A scholar is included among the top collaborators of Francesca Schieppati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Schieppati. Francesca Schieppati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tartari, Carmen Julia, Laura Russo, Silvia Bolognini, et al.. (2025). Thromboinflammatory Biomarkers Are Early Predictors of Disease Progression in Non-Small Cell Lung Cancer Patients. Cancers. 17(12). 1932–1932. 1 indexed citations

Bosch, Floris T.M., Pieter W. Kamphuisen, Stefano Barco, et al.. (2025). Management of recurrent venous thromboembolism during anticoagulant treatment in patients with cancer: a prospective cohort study. Journal of Thrombosis and Haemostasis. 23(12). 3932–3939.

Weiß, Luisa, Zhu Shen, Marina Marchetti, et al.. (2024). Platelet proteomic profiling reveals potential mediators of immunothrombosis and proteostasis in myeloproliferative neoplasms. Blood Advances. 8(16). 4276–4280. 4 indexed citations

Schieppati, Francesca. (2023). Post‐COVID‐19 thrombotic sequelae: The potential role of persistent platelet hyperactivity. British Journal of Haematology. 204(2). 383–385.

Kropf, Siegfried, Michael Koehler, Niklas Gebauer, et al.. (2023). Induction treatment in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: a systematic review and meta-analysis. Frontiers in Oncology. 13. 1188478–1188478. 2 indexed citations

Marchetti, Marina, Chiara Villa, Donatella Conconi, et al.. (2023). The Role of Coagulation Gene Polymorphisms in Sars-CoV2 Infection in the Bergamo Area. Blood. 142(Supplement 1). 5410–5410. 1 indexed citations

Marchetti, Marina, Laura Russo, Cristina Verzeroli, et al.. (2022). Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients. Frontiers in Cardiovascular Medicine. 9. 896362–896362. 12 indexed citations

Schieppati, Francesca, Laura Russo, Marina Marchetti, et al.. (2021). Hemostatic Markers, Adamts-13 Profile and Anti-Sars-Cov-2 Antibody Levels in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving BNT162b2 Vaccination. Blood. 138(Supplement 1). 1022–1022. 1 indexed citations

Falanga, Anna, Marina Marchetti, & Francesca Schieppati. (2021). Prevention and Management of Thrombosis in BCR/ABL-Negative Myeloproliferative Neoplasms. Hämostaseologie. 41(1). 48–57. 10 indexed citations

10.

Bernardi, Simona, Mirko Farina, Federica Cattina, et al.. (2020). ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial. SHILAP Revista de lepidopterología. 2020. 1–7. 6 indexed citations

11.

Borlenghi, Erika, Chiara Cattaneo, Elisa Cerqui, et al.. (2020). Postremission therapy with repeated courses of high‐dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long‐term outcome in European leukemia net favorable and intermediate‐risk acute myeloid leukemia. Hematological Oncology. 38(5). 754–762. 8 indexed citations

12.

Falanga, Anna, Francesca Schieppati, & Laura Russo. (2019). Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients. Cancer treatment and research. 179. 11–36. 57 indexed citations

13.

Schieppati, Francesca, Piera Balzarini, Simona Fisogni, et al.. (2019). An increase in MYC copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimens. Haematologica. 105(5). 1369–1378. 15 indexed citations

14.

D’Adda, Mariella, Mirko Farina, Francesca Schieppati, et al.. (2019). The e13a2 BCR‐ABL transcript negatively affects sustained deep molecular response and the achievement of treatment‐free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors. Cancer. 125(10). 1674–1682. 46 indexed citations

15.

D’Adda, Mariella, Mirko Farina, Francesca Schieppati, et al.. (2017). An e13a2 Type of BCR-ABL Transcript Has a Significant Adverse Impact on the Achievement of a Sustained Deep Molecular Response and on the Maintenance of a Treatment Free Remission after Stopping Tyrosine Kinase Inhibitors. Blood. 130. 1589–1589. 3 indexed citations

16.

Schieppati, Francesca, Angela Passi, Erika Borlenghi, et al.. (2017). Molecular Monitoring of NPM1 Is a Useful Tool for Detecting Early-Stage Relapse and to Guide Pre-Emptive Treatment Approaches in Patients with NPM1-Mutated Acute Myeloid Leukemia. Blood. 130. 3931–3931. 1 indexed citations

17.

Cerqui, Elisa, Francesca Schieppati, Erika Borlenghi, et al.. (2015). Lenalidomide in patients with red blood cell transfusion-dependent myelodysplastic syndrome and del(5q): a single-centre “real-world” experience. Leukemia & lymphoma. 56(11). 3129–3134. 1 indexed citations

18.

Schieppati, Francesca, et al.. (2015). Intravenous Immunoglobulin Is an Effective Treatment for LGL-Mediated Immune Cytopenias in Myelodysplastic Syndromes and Other Bone Marrow Failure Syndromes. Blood. 126(23). 1704–1704.

19.

Schieppati, Francesca, Domenico Russo, & Anna Falanga. (2015). Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with Cancer. Seminars in Thrombosis and Hemostasis. 41(7). 756–764. 76 indexed citations

20.

Cattaneo, Chiara, Mario Tumbarello, Cristina Skert, et al.. (2013). Relapsing bloodstream infections during treatment of acute leukemia. Annals of Hematology. 93(5). 785–790. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact